GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Greenrose Holding Co (OTCPK:GNRS) » Definitions » Peter Lynch Fair Value

The Greenrose Holding Co (The Greenrose Holding Co) Peter Lynch Fair Value : N/A (As of May. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is The Greenrose Holding Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for The Greenrose Holding Co's Peter Lynch Fair Value or its related term are showing as below:



GNRS's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.44
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


The Greenrose Holding Co Peter Lynch Fair Value Historical Data

The historical data trend for The Greenrose Holding Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Greenrose Holding Co Peter Lynch Fair Value Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
Peter Lynch Fair Value
- - -

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of The Greenrose Holding Co's Peter Lynch Fair Value

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co's Price-to-Peter-Lynch-Fair-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's Price-to-Peter-Lynch-Fair-Value falls into.



The Greenrose Holding Co Peter Lynch Fair Value Calculation

The Greenrose Holding Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0
=N/A

The Greenrose Holding Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $0.00.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


The Greenrose Holding Co  (OTCPK:GNRS) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

The Greenrose Holding Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.0001/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Greenrose Holding Co Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of The Greenrose Holding Co's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


The Greenrose Holding Co (The Greenrose Holding Co) Business Description

Traded in Other Exchanges
Address
111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
Executives
Bernard Wang officer: CHIEF FINANCIAL OFFICER 5575 TERRACE DR., LA CRESCENTA CA 91214
Benjamin Rose director 10115 JEFFERSON BOULEVARD, CULVER CITY CA 90232
True Harvest, Llc 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Michael Macchiaroli 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Scott Jeffrey Cohen officer: Chief Financial Officer C/O GREENROSE ASSOCIATES LLC, 111 BROADWAY, AMITYVILLE NY 11701
Greenrose Associates Llc 10 percent owner 1000 WESTBURY AVENUE, WESTBURY NY 11590
Steven Francis Cummings director, 10 percent owner 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
Daniel Patrick Harley director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
John Iii Torrance director, 10 percent owner 1000 WOODBURY ROAD, WOODBURY NY 11797
Thomas J Megale director 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
John Falcon director, 10 percent owner 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Jeffrey Stegner 10 percent owner, officer: Chief Financial Officer 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Brendan Sheehan director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
William Iii Harley director, 10 percent owner, officer: Chief Executive Officer 1000 WOODBURY ROAD, WOODBURY NY 11797
Paul Otto Wimer 10 percent owner, officer: President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797